CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma

M. Betti, Anna Aspesi, Alessandra Biasi, Elisabetta Casalone, D. Ferrante, Paola Ogliara, L. C. Gironi, R. Giorgione, P. Farinelli, F. Grosso, R. Libener, S. Rosato, Daniela Turchetti, Antonella Maffè, C. Casadio, V. Ascoli, Chiara Dianzani, E. Colombo, E. Piccolini, M. PavesiSara Miccoli, Dario Mirabelli, C. Bracco, L. Righi, Renzo Boldorini, M. Papotti, G. Matullo, C. Magnani, Barbara Pasini, I. Dianzani

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

BAP1 germline mutations predispose to a cancer predisposition syndrome that includes mesothelioma, cutaneous melanoma, uveal melanoma and other cancers. This co-occurrence suggests that these tumors share a common carcinogenic pathway. To evaluate this hypothesis, we studied 40 Italian families with mesothelioma and/or melanoma. The probands were sequenced for BAP1 and for the most common melanoma predisposition genes (i.e. CDKN2A, CDK4, TERT, MITF and POT1) to investigate if these genes may also confer susceptibility to mesothelioma. In two out of six families with both mesothelioma and melanoma we identified either a germline nonsense mutation (c.1153C > T, p.Arg385*) in BAP1 or a recurrent pathogenic germline mutation (c.301G > T, p.Gly101Trp) in CDKN2A. Our study suggests that CDKN2A, in addition to BAP1, could be involved in the melanoma and mesothelioma susceptibility, leading to the rare familial cancer syndromes. It also suggests that these tumors share key steps that drive carcinogenesis and that other genes may be involved in inherited predisposition to malignant mesothelioma and melanoma.

Original languageEnglish
Pages (from-to)120-130
Number of pages11
JournalCancer Letters
Volume378
Issue number2
DOIs
Publication statusPublished - Aug 10 2016

Fingerprint

Germ-Line Mutation
Mesothelioma
Melanoma
Neoplasms
p16 Genes
Nonsense Codon
Genes
Carcinogenesis
Skin

Keywords

  • Asbestos exposure
  • Cancer predisposition syndrome
  • Carcinogenesis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Betti, M., Aspesi, A., Biasi, A., Casalone, E., Ferrante, D., Ogliara, P., ... Dianzani, I. (2016). CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma. Cancer Letters, 378(2), 120-130. https://doi.org/10.1016/j.canlet.2016.05.011

CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma. / Betti, M.; Aspesi, Anna; Biasi, Alessandra; Casalone, Elisabetta; Ferrante, D.; Ogliara, Paola; Gironi, L. C.; Giorgione, R.; Farinelli, P.; Grosso, F.; Libener, R.; Rosato, S.; Turchetti, Daniela; Maffè, Antonella; Casadio, C.; Ascoli, V.; Dianzani, Chiara; Colombo, E.; Piccolini, E.; Pavesi, M.; Miccoli, Sara; Mirabelli, Dario; Bracco, C.; Righi, L.; Boldorini, Renzo; Papotti, M.; Matullo, G.; Magnani, C.; Pasini, Barbara; Dianzani, I.

In: Cancer Letters, Vol. 378, No. 2, 10.08.2016, p. 120-130.

Research output: Contribution to journalArticle

Betti, M, Aspesi, A, Biasi, A, Casalone, E, Ferrante, D, Ogliara, P, Gironi, LC, Giorgione, R, Farinelli, P, Grosso, F, Libener, R, Rosato, S, Turchetti, D, Maffè, A, Casadio, C, Ascoli, V, Dianzani, C, Colombo, E, Piccolini, E, Pavesi, M, Miccoli, S, Mirabelli, D, Bracco, C, Righi, L, Boldorini, R, Papotti, M, Matullo, G, Magnani, C, Pasini, B & Dianzani, I 2016, 'CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma', Cancer Letters, vol. 378, no. 2, pp. 120-130. https://doi.org/10.1016/j.canlet.2016.05.011
Betti M, Aspesi A, Biasi A, Casalone E, Ferrante D, Ogliara P et al. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma. Cancer Letters. 2016 Aug 10;378(2):120-130. https://doi.org/10.1016/j.canlet.2016.05.011
Betti, M. ; Aspesi, Anna ; Biasi, Alessandra ; Casalone, Elisabetta ; Ferrante, D. ; Ogliara, Paola ; Gironi, L. C. ; Giorgione, R. ; Farinelli, P. ; Grosso, F. ; Libener, R. ; Rosato, S. ; Turchetti, Daniela ; Maffè, Antonella ; Casadio, C. ; Ascoli, V. ; Dianzani, Chiara ; Colombo, E. ; Piccolini, E. ; Pavesi, M. ; Miccoli, Sara ; Mirabelli, Dario ; Bracco, C. ; Righi, L. ; Boldorini, Renzo ; Papotti, M. ; Matullo, G. ; Magnani, C. ; Pasini, Barbara ; Dianzani, I. / CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma. In: Cancer Letters. 2016 ; Vol. 378, No. 2. pp. 120-130.
@article{9cb4cf9da0994d4a909b4ccdfc6d8a26,
title = "CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma",
abstract = "BAP1 germline mutations predispose to a cancer predisposition syndrome that includes mesothelioma, cutaneous melanoma, uveal melanoma and other cancers. This co-occurrence suggests that these tumors share a common carcinogenic pathway. To evaluate this hypothesis, we studied 40 Italian families with mesothelioma and/or melanoma. The probands were sequenced for BAP1 and for the most common melanoma predisposition genes (i.e. CDKN2A, CDK4, TERT, MITF and POT1) to investigate if these genes may also confer susceptibility to mesothelioma. In two out of six families with both mesothelioma and melanoma we identified either a germline nonsense mutation (c.1153C > T, p.Arg385*) in BAP1 or a recurrent pathogenic germline mutation (c.301G > T, p.Gly101Trp) in CDKN2A. Our study suggests that CDKN2A, in addition to BAP1, could be involved in the melanoma and mesothelioma susceptibility, leading to the rare familial cancer syndromes. It also suggests that these tumors share key steps that drive carcinogenesis and that other genes may be involved in inherited predisposition to malignant mesothelioma and melanoma.",
keywords = "Asbestos exposure, Cancer predisposition syndrome, Carcinogenesis",
author = "M. Betti and Anna Aspesi and Alessandra Biasi and Elisabetta Casalone and D. Ferrante and Paola Ogliara and Gironi, {L. C.} and R. Giorgione and P. Farinelli and F. Grosso and R. Libener and S. Rosato and Daniela Turchetti and Antonella Maff{\`e} and C. Casadio and V. Ascoli and Chiara Dianzani and E. Colombo and E. Piccolini and M. Pavesi and Sara Miccoli and Dario Mirabelli and C. Bracco and L. Righi and Renzo Boldorini and M. Papotti and G. Matullo and C. Magnani and Barbara Pasini and I. Dianzani",
year = "2016",
month = "8",
day = "10",
doi = "10.1016/j.canlet.2016.05.011",
language = "English",
volume = "378",
pages = "120--130",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma

AU - Betti, M.

AU - Aspesi, Anna

AU - Biasi, Alessandra

AU - Casalone, Elisabetta

AU - Ferrante, D.

AU - Ogliara, Paola

AU - Gironi, L. C.

AU - Giorgione, R.

AU - Farinelli, P.

AU - Grosso, F.

AU - Libener, R.

AU - Rosato, S.

AU - Turchetti, Daniela

AU - Maffè, Antonella

AU - Casadio, C.

AU - Ascoli, V.

AU - Dianzani, Chiara

AU - Colombo, E.

AU - Piccolini, E.

AU - Pavesi, M.

AU - Miccoli, Sara

AU - Mirabelli, Dario

AU - Bracco, C.

AU - Righi, L.

AU - Boldorini, Renzo

AU - Papotti, M.

AU - Matullo, G.

AU - Magnani, C.

AU - Pasini, Barbara

AU - Dianzani, I.

PY - 2016/8/10

Y1 - 2016/8/10

N2 - BAP1 germline mutations predispose to a cancer predisposition syndrome that includes mesothelioma, cutaneous melanoma, uveal melanoma and other cancers. This co-occurrence suggests that these tumors share a common carcinogenic pathway. To evaluate this hypothesis, we studied 40 Italian families with mesothelioma and/or melanoma. The probands were sequenced for BAP1 and for the most common melanoma predisposition genes (i.e. CDKN2A, CDK4, TERT, MITF and POT1) to investigate if these genes may also confer susceptibility to mesothelioma. In two out of six families with both mesothelioma and melanoma we identified either a germline nonsense mutation (c.1153C > T, p.Arg385*) in BAP1 or a recurrent pathogenic germline mutation (c.301G > T, p.Gly101Trp) in CDKN2A. Our study suggests that CDKN2A, in addition to BAP1, could be involved in the melanoma and mesothelioma susceptibility, leading to the rare familial cancer syndromes. It also suggests that these tumors share key steps that drive carcinogenesis and that other genes may be involved in inherited predisposition to malignant mesothelioma and melanoma.

AB - BAP1 germline mutations predispose to a cancer predisposition syndrome that includes mesothelioma, cutaneous melanoma, uveal melanoma and other cancers. This co-occurrence suggests that these tumors share a common carcinogenic pathway. To evaluate this hypothesis, we studied 40 Italian families with mesothelioma and/or melanoma. The probands were sequenced for BAP1 and for the most common melanoma predisposition genes (i.e. CDKN2A, CDK4, TERT, MITF and POT1) to investigate if these genes may also confer susceptibility to mesothelioma. In two out of six families with both mesothelioma and melanoma we identified either a germline nonsense mutation (c.1153C > T, p.Arg385*) in BAP1 or a recurrent pathogenic germline mutation (c.301G > T, p.Gly101Trp) in CDKN2A. Our study suggests that CDKN2A, in addition to BAP1, could be involved in the melanoma and mesothelioma susceptibility, leading to the rare familial cancer syndromes. It also suggests that these tumors share key steps that drive carcinogenesis and that other genes may be involved in inherited predisposition to malignant mesothelioma and melanoma.

KW - Asbestos exposure

KW - Cancer predisposition syndrome

KW - Carcinogenesis

UR - http://www.scopus.com/inward/record.url?scp=84976330532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976330532&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2016.05.011

DO - 10.1016/j.canlet.2016.05.011

M3 - Article

AN - SCOPUS:84976330532

VL - 378

SP - 120

EP - 130

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -